2024-09-01 2025-08-31 true No description of principal activity Capium Accounts Production 1.1 15045774 2024-09-01 2025-08-31 15045774 bus:FullAccounts 2024-09-01 2025-08-31 15045774 bus:FRS102 2024-09-01 2025-08-31 15045774 bus:AuditExemptWithAccountantsReport 2024-09-01 2025-08-31 15045774 bus:SmallCompaniesRegimeForAccounts 2024-09-01 2025-08-31 15045774 bus:PrivateLimitedCompanyLtd 2024-09-01 2025-08-31 15045774 2024-09-01 2025-08-31 15045774 2025-08-31 15045774 bus:RegisteredOffice 2024-09-01 2025-08-31 15045774 core:WithinOneYear 2025-08-31 15045774 core:AfterOneYear 2025-08-31 15045774 1 2024-09-01 2025-08-31 15045774 bus:Director1 2024-09-01 2025-08-31 15045774 bus:Director1 2025-08-31 15045774 bus:Director1 2023-08-02 2024-08-31 15045774 2023-08-02 15045774 bus:LeadAgentIfApplicable 2024-09-01 2025-08-31 15045774 2023-08-02 2024-08-31 15045774 2024-08-31 15045774 core:WithinOneYear 2024-08-31 15045774 core:AfterOneYear 2024-08-31 15045774 bus:EntityAccountantsOrAuditors 2023-08-02 2024-08-31 15045774 core:CostValuation core:Non-currentFinancialInstruments 2025-08-31 15045774 core:CostValuation core:Non-currentFinancialInstruments 2024-08-31 15045774 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2025-08-31 15045774 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2025-08-31 15045774 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-08-31 15045774 core:Non-currentFinancialInstruments 2025-08-31 15045774 core:Non-currentFinancialInstruments 2024-08-31 15045774 core:ShareCapital 2025-08-31 15045774 core:ShareCapital 2024-08-31 iso4217:GBP xbrli:shares xbrli:pure
Reports Dated : 28/05/2026 Registered Number: 15045774
England and Wales

 

 

 

ERIESIS HEALTHCARE GROUP LTD.



Dormant Accounts
 


Period of accounts

Start date: 01 September 2024

End date: 31 August 2025
Director Enoh Rhoda ERIJAKPO
Registered Number 15045774
Registered Office 6 David Lane
NG6 0JU
1
The director presents his/her/their annual report and the financial statements for the year ended 31 August 2025.
The company is dormant and has not traded during the year.
Director

The director who served the company throughout the year was as follows:
Enoh Rhoda ERIJAKPO

On behalf of the board.


----------------------------------
Enoh Rhoda ERIJAKPO
Director

Date approved: 28 May 2026
2
 
 
Notes
 
2025
£
  2024
£
Current assets      
Cash at bank and in hand 100    100 
Net current assets 100    100 
 
Total assets less current liabilities 100    100 
Net assets 100    100 
 

Capital and reserves
     
Called up share capital 100    100 
Shareholders' funds 100    100 
 


For the year ended 31 August 2025 the company was entitled to exemption from audit under Section 480 of the Companies Act 2006 relating to dormant companies.

Director's responsibilities:
  1. The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
  2. The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
The financial statements were approved by the director on 28 May 2026 and were signed by:


-------------------------------
Enoh Rhoda ERIJAKPO
Director
3
General Information
ERIESIS HEALTHCARE GROUP LTD. is a private company, limited by shares, registered in England and Wales, registration number 15045774, registration address 6 David Lane, NG6 0JU.

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
Statement of compliance
These financial statements have been prepared in compliance with FRS 102 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.
Basis of preparation
The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies.
The financial statements are prepared in sterling which is the functional currency of the company.
4